• FirefoxInstall the new Firefox »
  •  Dow Up 0.86% Nasdaq Up 0.90%

    Ariad Pharmaceuticals Inc. (ARIA)

    -NasdaqGS
    8.03 Down 0.10(1.23%) Mar 2, 4:00PM EST
    |Pre-Market : 7.86 Down 0.17 (2.12%) 8:29AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:8.13
    Open:8.11
    Bid:7.90 x 200
    Ask:8.10 x 1000
    1y Target Est:8.35
    Beta:1.22
    Earnings Date:May 5 - May 11 (Est.)
    Day's Range:7.80 - 8.14
    52wk Range:4.90 - 8.85
    Volume:5,824,170
    Avg Vol (3m):6,519,220
    Market Cap:1.50B
    P/E (ttm):N/A
    EPS (ttm):-0.87
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ARIADown 1.23%1.50B
    NVSUp 0.49%240.03B
    PFEUp 1.31%213.10B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):14.44
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.03
    Quarterly EPS Est (Mar-15) :-0.33
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):-0.19

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ARIAD Pharmaceuticals, Inc., an oncology company, is engaged in the discovery, development, and commercialization of medicines for cancer patients. It offers Iclusig (ponatinib), a tyrosine kinase inhibitor for the treatment of adult patients with... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback